Skip to content
Ranked #285
Center for Medical Weight Loss (CMWL)

Budget-conscious patients wanting flat any-dose compounded glp-1 from an established program.

semaglutide
$149/mo
tirzepatide
$239/mo
Before enrolling

Some states are ineligible and the eligible-state list is not published

vs
Ranked #61Desk pick
Peter MD

Patients who want GLP-1 care alongside TRT, NAD+, sermorelin or other men's-health treatments under one physician-guided account, and don't need brand-name or oral routes.

semaglutide
$149/mointro + renewal; see terms
tirzepatide
$249/moquarterly term
Before enrolling

Tirzepatide steps up after month one — $149 for the first month, then $249/mo billed quarterly

Our review of Peter MD gives it 77/100 (C+), while our review of Center for Medical Weight Loss (CMWL) gives it 64/100 (C). The score breakdown shows where each provider does better.

Desk Score, dimension by dimension

Same six measured dimensions for both. The green bar marks the stronger score. See the methodology.

Center for Medical Weight Loss (CMWL)

64/100

C

Overall

Peter MD

77/100

C+

Price transparency

84
78

State access

24
62

Molecule range

66
92

Onboarding speed

73
80

Support responsiveness

70
72

Licensing & trust

70
78

The spec sheet

Check the billing terms before comparing the figures. Our guide to paying for GLP-1 care without insurance explains how medication charges, membership fees and prepaid terms affect what you owe.

FieldCenter for Medical Weight Loss (CMWL)Peter MD
Semaglutide$149/mo
Full plan terms

$149/mo (all doses, compounded)

$149/mointro + renewal; see terms
Full plan terms

$149/mo (GLP1+B12, compounded, first-time tier billed $447 up front for an estimated 10–12 week supply; returning-patient tier $139/mo, billed $834 up front)

Tirzepatide$239/mo
Full plan terms

$239/mo (all doses, compounded)

$249/moquarterly term
Full plan terms

$249/mo (60mg, billed quarterly; $149 first month)

CoverageNot confirmed for Center for Medical Weight Loss (CMWL).Most states (restrictions vary by treatment — tirzepatide excludes AL and ID; semaglutide also excludes AK and HI)
Brand-nameNot confirmed hereNot confirmed here
Oral optionNot confirmed hereNot confirmed here
Best forBudget-conscious patients wanting flat any-dose compounded glp-1 from an established program.Patients who want GLP-1 care alongside TRT, NAD+, sermorelin or other men's-health treatments under one physician-guided account, and don't need brand-name or oral routes.
Desk Score64/100C77/100C+

The verdict

Desk pick — Peter MD

Peter MD has the higher Desk Score, but Center for Medical Weight Loss (CMWL) may be a better fit if it covers your state, offers the prescribed product or has billing terms that work better for you.

Choose Center for Medical Weight Loss (CMWL) if…

Budget-conscious patients wanting flat any-dose compounded glp-1 from an established program.

$149/mo sema · $239/mo tirz

Choose Peter MD if…

Patients who want GLP-1 care alongside TRT, NAD+, sermorelin or other men's-health treatments under one physician-guided account, and don't need brand-name or oral routes.

$149/mo (intro + renewal; see terms) sema · $249/mo (quarterly term) tirz · Most states (restrictions vary by treatment — tirzepatide excludes AL and ID; semaglutide also excludes AK and HI)

Assume any provider we list may compensate us. We may earn a referral commission at no extra cost to you, and compensation does not change the Desk Score.

Also here

CoreAge Rx leads the whole ranking at 94/100

Whichever of these two you lean toward, our #1-rated provider outscores them both. Both compounded injections with dose-independent advertised rates. The $79 and $129 monthly equivalents require a year paid in full; confirm the total charge and refund terms.

More head-to-heads

Or see the full comparison hub and the complete ranking.

Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.